Clinical Trial: Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants

U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07182552) titled 'Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants' on Aug. 18.

Brief Summary: This study is a randomized, double-blind, dose-escalation Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetic/pharmacodynamic characteristics of NTB003 injection in healthy volunteers.

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: TED

Intervention: DRUG: NTB003

NTB003 dose 1, dose 2, dose 3, dose 4

DRUG: Placebo

Placebo dose 1, dose 2, dose 3, dose 4

Recruitment Status: ENROLLING_BY_INVITATION

Sponsor: Nanjing Chia-tai Tianqing Pharm...